Jonathan A. Ledermann
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment 198
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments 49
- Oncology top 0.1%
- PARP inhibition in cancer therapy 114
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 17
- Hepatology top 0.5%
-
- BRCA gene mutations in cancer 53
-
- Intraperitoneal and Appendiceal Malignancies 39
-
- Renal cell carcinoma treatment 24
-
- Cancer Mechanisms and Therapy 14
- Co-authors
- Gordon C. JaysonElise C. KohnHenry C KitchenerNicoletta ColomboAntonio González-Martı́nMichael FriedländerGordon RustinPhilipp Harter
- Journals
- Journal of Clinical Oncology (60 papers)Annals of Oncology (43 papers)International Journal of Gynecological Cancer (34 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Jonathan A. Ledermann
286 papers receiving 17.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Reproductive Medicine 8.0k
- Obstetrics and Gynecology 2.7k
- Oncology 9.2k
- Cancer Research 2.2k
- Hepatology 1.1k
Countries citing papers authored by Jonathan A. Ledermann
This map shows the geographic impact of Jonathan A. Ledermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Ledermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Ledermann more than expected).
Fields of papers citing papers by Jonathan A. Ledermann
This network shows the impact of papers produced by Jonathan A. Ledermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Ledermann. The network helps show where Jonathan A. Ledermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan A. Ledermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 31 | |
| 13 | 2019 | 24 | |
| 14 | Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer | 2016 | 1 |
| 15 | 2014 | 14 | |
| 16 | 2013 | 58 | |
| 17 | 2011 | 164 | |
| 18 | 2009 | 59 | |
| 19 | 2007 | 1 | |
| 20 | 1993 | 2 |
About Jonathan A. Ledermann
Jonathan A. Ledermann is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 295 papers that have together received 17.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (198 papers), PARP inhibition in cancer therapy (114 papers), BRCA gene mutations in cancer (53 papers), Endometrial and Cervical Cancer Treatments (49 papers), Intraperitoneal and Appendiceal Malignancies (39 papers), Renal cell carcinoma treatment (24 papers), Cancer Genomics and Diagnostics (17 papers) and Cancer Mechanisms and Therapy (14 papers). The work is most often cited by research in Reproductive Medicine (8.0k citations), Obstetrics and Gynecology (2.7k citations) and Oncology (9.2k citations). Jonathan A. Ledermann has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gordon C. Jayson, Elise C. Kohn, Henry C Kitchener, Nicoletta Colombo, Antonio González-Martı́n, Michael Friedländer, Gordon Rustin, Philipp Harter, Charlie Gourley and Ignace Vergote. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.